Dongling Gao
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Exosomal gene signature in esophageal carcinoma: Insights from single-cell and bulk RNA sequencing.
Journal: Translational oncology
Published: May 09, 2025
The integrated molecular and histological analysis defines subtypes of esophageal squamous cell carcinoma.
Journal: Nature communications
Published: August 05, 2021
Cancer spectrum in TP53-deficient golden Syrian hamsters: A new model for Li-Fraumeni syndrome.
Journal: Journal of carcinogenesis
Published: May 28, 2021
Correction: A Virus-infected, Reprogrammed Somatic Cell-derived Tumor Cell (VIReST) Vaccination Regime can Prevent Initiation and Progression of Pancreatic Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 04, 2021
Treatment and Prevention of Lung Cancer Using a Virus-Infected Reprogrammed Somatic Cell-Derived Tumor Cell Vaccination (VIReST) Regime.
Journal: Frontiers in immunology
Published: March 23, 2020
A new oncolytic Vacciniavirus augments antitumor immune responses to prevent tumor recurrence and metastasis after surgery.
Journal: Journal for immunotherapy of cancer
Published: December 19, 2019
A Virus-Infected, Reprogrammed Somatic Cell-Derived Tumor Cell (VIReST) Vaccination Regime Can Prevent Initiation and Progression of Pancreatic Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 30, 2019
Author Correction: Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent.
Journal: Nature communications
Published: January 12, 2018
Correction for Spurrell et al., "STAT1 Interaction with E3-14.7K in Monocytes Affects the Efficacy of Oncolytic Adenovirus".
Journal: Journal of virology
Published: September 29, 2017
Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent.
Journal: Nature communications
Published: January 11, 2017
A vaccinia virus armed with interleukin-10 is a promising therapeutic agent for treatment of murine pancreatic cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 23, 2014
Last Updated: 09/26/2026